Results 101 to 110 of about 12,630 (165)
Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil [PDF]
Philip D. Marsden
openalex +1 more source
Is Visceral Leishmaniasis the same in HIV-coinfected adults?
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania donovani complex, with significant morbidity and mortality in developing countries.
Guilherme Alves de Lima Henn+7 more
doaj
Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice
Lloyd L. Smrkovski, C. L. Larson
openalex +1 more source
Multi‐centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis [PDF]
Marleen Boelaert+10 more
openalex +1 more source
Cost-Effectiveness Analysis of Humanitarian Relief Interventions: Visceral Leishmaniasis Treatment in the Sudan [PDF]
André Griekspoor+2 more
openalex +1 more source
Immunity and immunosuppression in experimental visceral leishmaniasis
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj
Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis [PDF]
C. Fargeas+5 more
openalex +1 more source
Objectives: Sustainable elimination of visceral leishmaniasis as a public health problem requires the contribution of various stakeholders led by the governments.
Duncan Ochol+4 more
doaj